Controversies and Open Questions in Management of Cancer-Free Carriers of Germline Pathogenic Variants in <i>BRCA1/BRCA2</i>.

Bernstein-Molho, Rinat; Friedman, Eitan; Evron, Ella

Controversies and Open Questions in Management of Cancer-Free Carriers of Germline Pathogenic Variants in BRCA1/BRCA2.

Bernstein-Molho, Rinat; Friedman, Eitan; Evron, Ella.

Afiliação

Bernstein-Molho R; The Oncogenetics Unit, Chaim Sheba Medical Center, Tel-Hashomer, The Sackler School of Medicine, Tel-Aviv University, Tel-Aviv 5265601, Israel.
Friedman E; Assuta Medical Center, Tel-Aviv, Israel, The Sackler School of Medicine, Tel-Aviv University, Tel-Aviv 8436322, Israel.
Evron E; Oncology, Kaplan Medical Institute, Rehovot, Hadassah Medical School, The Hebrew University, Jerusalem 9190501, Israel.

Cancers (Basel) ; 14(19)2022 Sep 22.

Article em En | MEDLINE | ID: mdl-36230512

Palavras-chave

BRCA1/BRCA2; early detection scheme; guidelines; management; risk-reducing surgery; surveillance

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Screening_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Israel

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google